Figure 1

Kaplan–Meier survival curves showing overall survival rates (A), disease-free survival rates (B), distant metastasis–free survival rates (C) and local relapse–free survival rates (D) in nasopharyngeal carcinoma patients with elevated or normal post-treatment levels of lactate dehydrogenase (LDH).